false0001006837295 Madison Avenue12th FloorNew YorkNY00010068372022-06-242022-06-24





Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): June 24, 2022

(Exact name of registrant as specified in its charter)
Delaware 001-35210 54-1708481
(State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.)
295 Madison Avenue, 12th Floor
New York, NY
(Address of principal executive offices)   (Zip Code)
Registrant’s telephone number, including area code:  
(212) 235-2690
Former name or former address, if changed since last report

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol Name of each exchange on which registered
Common Stock, par value $0.001 per share VATE New York Stock Exchange
Preferred Stock Purchase Rights
N/A New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company  ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

On June 24, 2022, INNOVATE Corp. (the “Company”) notified the New York Stock Exchange (“NYSE”) that the Company was no longer in compliance with Section 303A.07(a) of the NYSE Listed Company Manual (the “NYSE Manual”) corporate governance standards, which requires, among other things, that the audit committee of a listed company have at least three independent directors. Following the appointment of Brian Goldstein as described in Item 5.02 of this Form 8-K, the Audit Committee of the Board of Directors of the Company (the “Board”) has two independent directors. The Company is continuing to identify independent director candidates and intends to complete the process as soon as practicable.

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

On June 28, 2022, the Board appointed Brian Goldstein as a director to fill one of the vacancies on the Board and decreased the size of the Board from six directors to five directors in accordance with the Company’s Bylaws. Following the appointment of Mr. Goldstein, the Board currently consists of four members, three of whom are independent, with one remaining vacancy.

Mr. Goldstein will serve as a director until the Company’s 2023 Annual Meeting of Stockholders and until his successor is duly elected and qualified or until his earlier death, resignation or removal. In addition, Mr. Goldstein was appointed to serve as the Chairman of the Audit Committee and as a member of the Compensation Committee and the Nominating and Governance Committee.

The Board has determined that Mr. Goldstein qualifies as an independent director under the applicable rules of the NYSE and the rules and regulations of the Securities and Exchange Commission (“SEC”). There are no transactions between the Company and Mr. Goldstein that would require disclosure under Item 404(a) of Regulation S-K. Mr. Goldstein will participate in the Company’s compensation program for non-employee directors as described under the caption “Compensation of Directors” in the definitive proxy statement for the Company’s 2022 Annual Meeting of Stockholders filed with the SEC on April 27, 2022. The Company will also enter into an indemnification agreement with Mr. Goldstein in the form attached as Exhibit 10.12 to the Company’s most recent Annual Report on Form 10-K. Mr. Goldstein will also continue to serve as a director on the Board of DBM Global Inc., a subsidiary of the Company, where he has served since 2021.

Item 7.01. Regulation FD Disclosure.

On June 29, 2022, the Company issued a press release announcing Mr. Goldstein’s appointment to the Board. The press release related to this announcement is attached hereto as Exhibit 99.1.

The information above is being furnished, not filed, pursuant to Item 7.01 of Form 8-K. Accordingly, the information in Item 7.01 of this Form 8-K, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities under that Section and shall not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, unless specifically identified therein as being incorporated by reference.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits
Exhibit No. Description
104 Cover Page Interactive Data File (embedded within the Inline XBRL document).

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: June 29, 2022
INNOVATE Corp. (Registrant)
By: /s/ Michael J. Sena
Name: Michael J. Sena
Title: Chief Financial Officer

Historical Stock Chart
Von Nov 2022 bis Dez 2022 Click Here for more HC2 Charts.
Historical Stock Chart
Von Dez 2021 bis Dez 2022 Click Here for more HC2 Charts.